NCT06374186Completed
Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City
Source: ClinicalTrials.gov · Last updated 7 Jan 2026
Brief summary (registry, in English)
This study is evaluating a behavioral treatment program that uses diabetes coaching and financial rewards in addition to continuous glucose monitoring to improve diabetes management in adult patients with type 2 diabetes. This study will evaluate if this behavioral treatment program increases individual adherence to a diabetes treatment plan and improves blood sugar management.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 26 (actual)
- First submitted
- 15 Apr 2024
- Start date
- 1 May 2024
- Primary completion date
- 29 Jul 2025
- Lead sponsor
- University of Missouri, Kansas City
- Diseases
- Type 2 diabetes
- NCT number
- NCT06374186
What you commit to
- Study type: Interventional
- Participants enrolled: 26
- From 1 May 2024 to the primary completion date, 29 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Type 1 diabetes
- Secondary type 2 diabetes (diagnosis secondary to other medical conditions such as pancreatitis, Cystic Fibrosis, or Cushing disease)
- Prescribed short-acting (mealtime) insulin as part of diabetes treatment plan
- Known or acknowledged active substance use disorder or that would interfere or negatively impact participation in the study
- Diagnosis of a medical/psychiatric condition that would prevent participation in the study (e.g., Intellectual Disability, Alzheimer's disease, Traumatic Brain Injury, Schizophrenia)
Who the study is looking for
- Diagnosed with type 2 diabetes
- Age 18 to 65
- Hemoglobin A1c (blood draw or point-of-care) test available within the last 3 months
- Most recent hemoglobin A1c result between 8.0 and 11.0
- Currently receiving treatment for diabetes by a licensed healthcare provider.
- Reliable access to a personal smart phone that is compatible with CGM
- English speaking
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Missouri - Kansas City School of Medicine Coordinator of this site? Confirm its status | Kansas City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.